C4 Therapeutics
CCCC
CCCC
83 hedge funds and large institutions have $927M invested in C4 Therapeutics in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 21 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
11% more funds holding
Funds holding: 75 → 83 (+8)
5.43% more ownership
Funds ownership: 52.77% → 58.2% (+5.4%)
Holders
83
Holding in Top 10
7
Calls
–
Puts
–
Top Buyers
| 1 | +$40.1M | |
| 2 | +$25.8M | |
| 3 | +$21M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$11.8M |
| 5 |
Jennison Associates
New York
|
+$11.8M |
Top Sellers
| 1 | -$13.9M | |
| 2 | -$13.5M | |
| 3 | -$12.3M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
-$4.75M |
| 5 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$4.62M |